| Names | |
|---|---|
|
IUPAC name
6-(Benzyloxy)-7H-purin-2-amine
|
|
| Other names
6-(Benzyloxy)guanine; 6-O-Benzylguanine; O(6)-bGua; O6-BG
|
|
| Identifiers | |
|
3D model (Jmol)
|
|
| ChemSpider | |
| ECHA InfoCard | 100.161.788 |
|
PubChem CID
|
|
|
|
|
|
| Properties | |
| C12H11N5O | |
| Molar mass | 241.25 g·mol−1 |
| Density | 1.432 g/mL |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
| Infobox references | |
O6-Benzylguanine (O6-BG) is a synthetic derivative of guanine. It is an antineoplastic agent. It exerts its effect by acting as an suicide inhibitor of the enzyme O6-alkylguanine-DNA alkyltransferase which leads to interruption of DNA repair. O6-BG was used clinically in combination with the alkylating agent temozolomide for glioblastoma, however the combination was found to be overly toxic without adding significant benefit.
O6-BG is also used as a biochemical tool in the study of DNA repair mechanisms.